Swiss National Bank’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Swiss National Bank's CLBT Position: Q2 2026 in Review
Swiss National Bank increased its Cellebrite (CLBT) stake by 15% in Q2 2026, buying an estimated $444K and bringing the position to 251,400 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1616.
Swiss National Bank first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.93M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Swiss National Bank held 251,400 shares of Cellebrite worth $3.67M as of Q2 2026.
- Swiss National Bank bought 33,600 Cellebrite shares in Q2 2026, an estimated $444K.
- Cellebrite made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1616 holding.
- Swiss National Bank first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
- Swiss National Bank's Cellebrite position peaked at $3.93M in Q4 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.